farnesol and Arteriosclerosis

farnesol has been researched along with Arteriosclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernini, F; Corsini, A; Fumagalli, R; Paoletti, R; Raiteri, M; Soma, MR1
Afek, A; George, J; Goldberg, I; Haklai, R; Herz, I; Keren, G; Keren, P; Kloog, Y1

Other Studies

2 other study(ies) available for farnesol and Arteriosclerosis

ArticleYear
Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    The American journal of cardiology, 1995, Jul-13, Volume: 76, Issue:2

    Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Cell Division; Cell Movement; Cells, Cultured; Cholesterol Esters; Diterpenes; Farnesol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Macrophages, Peritoneal; Male; Mevalonic Acid; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Pravastatin; Rabbits; Rats; Rats, Sprague-Dawley; Simvastatin

1995
Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice.
    Circulation, 2002, May-21, Volume: 105, Issue:20

    Topics: Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Autoantibodies; Cell Division; Cells, Cultured; Cholesterol; Dietary Fats; Disease Models, Animal; Enzyme Inhibitors; Farnesol; Injections, Intraperitoneal; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; ras Proteins; Salicylates; Spleen; Treatment Outcome; Triglycerides; Vascular Cell Adhesion Molecule-1

2002